Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 2/Signature 1

From BugSigDB
Needs review

Curated date: 2024/04/19

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 1E

Description: Variable importance plot (VIP) scores obtained within partial least square discriminant analysis describing the most discriminant species in Post-CT TNM stage I (orange) compared to Post-CT TNM stage II-III (blue)

Abundance in Group 1: increased abundance in Post-CT Stage II/III

NCBI Quality ControlLinks
Gordonibacter pamelaeae
Blautia wexlerae
Sellimonas intestinalis
Phascolarctobacterium succinatutens
Anaerotignum lactatifermentans
Bacteroides clarus
Bacteroides uniformis
Thomasclavelia ramosa
Ruthenibacterium lactatiformans
Enterocloster citroniae
Eggerthella lenta
Roseburia intestinalis
Enterocloster bolteae
Enterocloster clostridioformis
Parabacteroides merdae
Harryflintia acetispora
Enterocloster aldenensis
Eisenbergiella massiliensis
Enterococcus durans
Blautia producta
Bacteroides stercoris
Bacteroides nordii
Veillonella parvula
Clostridium sp. CAG:167
Blautia sp. CAG:257
Veillonella tobetsuensis
[Clostridium] leptum
Eubacterium sp. CAG:180
Streptococcus thermophilus
Coprobacillus cateniformis
Clostridiales bacterium 1_7_47FAA

Revision editor(s): Scholastica